Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Transine Therapeutics Ltd.

Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company’s pioneering technology is expected to offer an entirely unique mechanism of action for currently hard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases which have been beyond the reach of small molecules, conventional biologics or gene therapies. Transine, which was founded in 2020 and is headquartered in Cambridge UK, is backed by Takeda Ventures, Inc. and the Dementia Discovery Fund. *


Period Start 2018-08-22 established
Products Industry BIOTECH
  Industry 2 SINEUPs®
Persons Person Gustincich, Stefano (Italian Institute of Technology, Geneo + Co-Founder of Transine Therapeutics)
  Person 2 Carninci, Piero (Human Technopole + Riken Center for Integrative Medical Sciences + Co-Founder Transine Therapeutics)
Region Region Cambridge, Cambridgeshire
  Country United Kingdom (GB)
  Street Babraham Hall
Babraham Research Campus
  City CB22 3AT Cambridge, Cambridgeshire
    Address record changed: 2021-06-05
Basic data Employees n. a.
    * Document for �About Section�: Transine Therapeutics Ltd.. (6/2/21). "Press Release: Transine Therapeutics Closes Extended Seed Funding of £9.1 Million Co-led by Takeda Ventures, Inc. and the Dementia Discovery Fund to Advance Its Novel Class of Therapeutic RNAs". Cambridge.
Record changed: 2021-06-05


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Transine Therapeutics Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture [iito] Back into Ad 650x80px

» top